The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia
NCT ID: NCT04143308
Last Updated: 2024-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2019-11-05
2021-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
NCT04411979
Cognitive and Balance Dual Task Training for People With Schizophrenia
NCT05341804
Baduanjin Versus Brisk Walking for Cognition in Schizophrenia
NCT06226779
The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia.
NCT01897064
Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.
NCT04916483
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Purposes: To examine the effects of the training program on cognitive functions, fitness, functional performance and quality of life.
Methods: A 3-arm, single-blinded, randomized controlled trial is used to recruit 90 participants and then randomly allocated to the simultaneous training group, the cognitive training group, and the treatment as usual group. The first two training groups receive training for 30-40 minutes, 3 times a week for 12 weeks, as well as a follow-up of 12 weeks. All participants will be assessed at baseline, post-test and follow-up assessment. Primary outcome is cognitive function and secondary outcomes are fitness, functional performance, and quality of life.
Contribution: The study can be used as an evidence-based program to improve cognitive functioning of people with schizophrenia. With the development of mobile App and the use of fitness wearable device, the training program enables people with schizophrenia to walk and practice cognitive training simultaneously in a group format. It will help clinical professionals be able to serve the increasing number of people with severe mental illness with less manpower and specialized equipment. The study is also helpful to better understanding the isolated role of aerobic exercise in the dual-task training, and to apply to other groups, like the elderly or dementia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Simultaneous training of walking and cognitive group
1. Wearable technology (fitness wristband \& App)
2. SWATCH system (App \& controller)
3. 3 times a week (30 mins/ each time)
4. Lasts for 12 weeks
5. Simultaneous walking and cognitive training
Simultaneous training of walking and cognitive group
Device:
1. SWATCH system (App \& controller)
2. Wearable technology Fitness wristband \& APP
Cognitive training group
1. Wearable technology (fitness wristband \& App)
2. SWATCH system (App)
3. 3 times a week (30 mins/ each time)
4. Lasts for 12 weeks
5. Cognitive training while sitting
Cognitive training group
Device:
1. SWATCH system (App)
2. Wearable technology Fitness wristband \& APP
Treatment as usual group
1\. Keep treatment as usual group at health care system.
Treatment as usual group
Keep treatment as usual
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Simultaneous training of walking and cognitive group
Device:
1. SWATCH system (App \& controller)
2. Wearable technology Fitness wristband \& APP
Cognitive training group
Device:
1. SWATCH system (App)
2. Wearable technology Fitness wristband \& APP
Treatment as usual group
Keep treatment as usual
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 20-60 years old.
3. Living in daycare center or community-based mental health rehabilitation services or rehabilitation ward.
4. Having stable psychiatric conditions (i.e., primary psychiatric medications had not changed for more than two months)
5. The MATRICS Consensus Cognitive Battery (MCCB) (Nuechterlein et al., 2008) shows that at least one domain with cognitive impairment (below the value of -1SD).
6. Can follow the research process and sign the consent form.
Exclusion Criteria
2. Pregnancy, cardiovascular disease, and unsuitable to exercise training due to physical movement difficulties
3. According participants' self-report, having following conditions, including severe heart failure, myocardial infarction, angina pectoris, chronic obstructive pulmonary disease, COPD, poor glycemic control (i.e., dialysis, diabetic neuropathy or retinopathy) and lower extremity arthritis
4. Uncontrolled hypertension with SBP\> 160 mmHg or DBP\> 110 mmHg
5. Diagnosis of intellectual disability
6. Unconscious or confusion of consciousness
7. Participating in other intervention studies
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ming-De Chen, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Occupational Therapy, College of Health Sciences, Kaohsiung Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ming-De Chen
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KMUHIRB-SV(I)-20170080
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.